Seek Returns logo

ISRG vs. TEM: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at ISRG and TEM, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolISRGTEM
Company NameIntuitive Surgical, Inc.Tempus AI, Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Equipment & SuppliesLife Sciences Tools & Services
Market Capitalization172.23 billion USD12.73 billion USD
ExchangeNasdaqGSNasdaqGS
Listing DateJune 16, 2000June 14, 2024
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of ISRG and TEM by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

ISRG vs. TEM: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolISRGTEM
5-Day Price Return0.71%2.36%
13-Week Price Return-14.45%14.97%
26-Week Price Return-18.76%-12.50%
52-Week Price Return-0.35%27.20%
Month-to-Date Return-0.13%29.49%
Year-to-Date Return-7.95%117.06%
10-Day Avg. Volume1.62M15.32M
3-Month Avg. Volume1.82M12.07M
3-Month Volatility21.21%79.77%
Beta1.643.14

Profitability

Return on Equity (TTM)

ISRG

15.55%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

ISRG’s Return on Equity of 15.55% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.

TEM

-107.12%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

TEM has a negative Return on Equity of -107.12%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

ISRG vs. TEM: A comparison of their Return on Equity (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Net Profit Margin (TTM)

ISRG

28.51%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

ISRG’s Net Profit Margin of 28.51% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.

TEM

-20.98%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

TEM has a negative Net Profit Margin of -20.98%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

ISRG vs. TEM: A comparison of their Net Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Operating Profit Margin (TTM)

ISRG

28.80%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

An Operating Profit Margin of 28.80% places ISRG in the upper quartile for the Health Care Equipment & Supplies industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

TEM

-24.66%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

TEM has a negative Operating Profit Margin of -24.66%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.

ISRG vs. TEM: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Profitability at a Glance

SymbolISRGTEM
Return on Equity (TTM)15.55%-107.12%
Return on Assets (TTM)13.75%-15.77%
Net Profit Margin (TTM)28.51%-20.98%
Operating Profit Margin (TTM)28.80%-24.66%
Gross Profit Margin (TTM)66.61%60.73%

Financial Strength

Current Ratio (MRQ)

ISRG

5.64

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

ISRG’s Current Ratio of 5.64 is exceptionally high, placing it well outside the typical range for the Health Care Equipment & Supplies industry. This indicates a very strong liquidity position, though such a high ratio may also suggest that the company is not using its assets efficiently to generate profits.

TEM

1.54

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

TEM’s Current Ratio of 1.54 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

ISRG vs. TEM: A comparison of their Current Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

ISRG

0.00

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

Falling into the lower quartile for the Health Care Equipment & Supplies industry, ISRG’s Debt-to-Equity Ratio of 0.00 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

TEM

2.58

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

With a Debt-to-Equity Ratio of 2.58, TEM operates with exceptionally high leverage compared to the Life Sciences Tools & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

ISRG vs. TEM: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Interest Coverage Ratio (TTM)

ISRG

--

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

Interest Coverage Ratio data for ISRG is currently unavailable.

TEM

-14.08

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

TEM has a negative Interest Coverage Ratio of -14.08. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.

ISRG vs. TEM: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Financial Strength at a Glance

SymbolISRGTEM
Current Ratio (MRQ)5.641.54
Quick Ratio (MRQ)4.891.34
Debt-to-Equity Ratio (MRQ)0.002.58
Interest Coverage Ratio (TTM)---14.08

Growth

Revenue Growth

ISRG vs. TEM: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

ISRG vs. TEM: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

ISRG

0.00%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

ISRG currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

TEM

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

TEM currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

ISRG vs. TEM: A comparison of their Dividend Yield (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Dividend Payout Ratio (TTM)

ISRG

0.00%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

ISRG has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

TEM

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

TEM has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

ISRG vs. TEM: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Dividend at a Glance

SymbolISRGTEM
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

ISRG

66.01

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

A P/E Ratio of 66.01 places ISRG in the upper quartile for the Health Care Equipment & Supplies industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

TEM

--

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

P/E Ratio data for TEM is currently unavailable.

ISRG vs. TEM: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

ISRG

18.82

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

With a P/S Ratio of 18.82, ISRG trades at a valuation that eclipses even the highest in the Health Care Equipment & Supplies industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

TEM

13.37

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

With a P/S Ratio of 13.37, TEM trades at a valuation that eclipses even the highest in the Life Sciences Tools & Services industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

ISRG vs. TEM: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

ISRG

10.85

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

ISRG’s P/B Ratio of 10.85 is in the upper tier for the Health Care Equipment & Supplies industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

TEM

35.53

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

At 35.53, TEM’s P/B Ratio is at an extreme premium to the Life Sciences Tools & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

ISRG vs. TEM: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Valuation at a Glance

SymbolISRGTEM
Price-to-Earnings Ratio (TTM)66.01--
Price-to-Sales Ratio (TTM)18.8213.37
Price-to-Book Ratio (MRQ)10.8535.53
Price-to-Free Cash Flow Ratio (TTM)86.31--